The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.

It brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers.

The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.

 

Let’s meet: reach out to our Business Development Team at bd@regulatorypharmanet.com

 

Comments are closed for this post.